BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inuzuka LM, Macedo-Souza LI, Della-Ripa B, Monteiro FP, Ramos L, Kitajima JP, Garzon E, Kok F. Additional observation of a de novo pathogenic variant in KCNT2 leading to epileptic encephalopathy with clinical features of frontal lobe epilepsy. Brain Dev 2020;42:691-5. [PMID: 32773162 DOI: 10.1016/j.braindev.2020.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gong P, Jiao X, Yu D, Yang Z. Case Report: Causative De novo Variants of KCNT2 for Developmental and Epileptic Encephalopathy. Front Genet 2021;12:649556. [PMID: 34276763 DOI: 10.3389/fgene.2021.649556] [Reference Citation Analysis]
2 Jackson A, Banka S, Stewart H, Robinson H, Lovell S, Clayton-Smith J; Genomics England Research Consortium. Recurrent KCNT2 missense variants affecting p.Arg190 result in a recognizable phenotype. Am J Med Genet A 2021. [PMID: 34061450 DOI: 10.1002/ajmg.a.62370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun H, Shen XR, Fang ZB, Jiang ZZ, Wei XJ, Wang ZY, Yu XF. Next-Generation Sequencing Technologies and Neurogenetic Diseases. Life (Basel) 2021;11:361. [PMID: 33921670 DOI: 10.3390/life11040361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Nikitin ES, Vinogradova LV. Potassium channels as prominent targets and tools for the treatment of epilepsy. Expert Opin Ther Targets 2021;25:223-35. [PMID: 33754930 DOI: 10.1080/14728222.2021.1908263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]